Drug Database
Back to search

Finland· FI-REL-REL2182

Nalador

A sulproston product containing sulprostone, registered in Finland by Schering Oy. The same ATC class is registered in 4 of our 19 countries.

ATC G02AD05

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNaladorATCG02AD05REGISTER NO.FI-REL-REL2182PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sulprostoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sulproston is registered in 4 of 19 countries.

Countries holding a registration under ATC G02AD05 (sulproston), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 3 of them publish a price we can compare per daily dose
Search sulproston products by name

Sulproston · ATC G02AD05

4 / 19 countries

  • Finlandprice
  • Franceprice
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Sulprostone
Manufacturer
Schering Oy
Country
Finland (FI)
ATC code
G02AD05
ATC class
Sulproston
Defined daily dose
0.5 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sulproston in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulproston products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Nalador
  • Germany · Nalador-500
  • France · Nalador
  • Hungary · Nalador
  • Italy · Nalador
  • Netherlands · Nalador
  • Portugal · Nalador 500

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea80e3db-e7ac-4824-89fd-c39f48ae422c
GET /v1/drugs/ea80e3db-e7ac-4824-89fd-c39f48ae422c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.5",
  "form": "infuusiokuiva-aine, liuosta varten",
  "route": null,
  "ddd_unit": "mg",
  "strength": "0.5 mg",
  "atc_label": "sulprostoni",
  "ma_number": "9552",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2182",
  "authorised_at": "1987-11-04"
}
API referenceMCP serverPlans

See everything about sulproston.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console